NEW DIAGNOSIS AND THERAPY METHOD OF CUTANEOUS T CELL LYMPHOMA (CTCL) 皮膚T細胞リンパ腫(CTCL)の新規な診断及び治療法 - 特許庁
This method is characterized by including the following step, and used for obtaining a numerical value of an existence ratio of virulent CD4+CTCL cells in a specific in-body section of a patient. 下記の段階を含むことを特徴とする、患者の特定の体内区分内の、悪性CD4+CTCL細胞の存在比率の数値を求める方法。 - 特許庁
The value of a ratio of CD4 cells developing p140 molecules is measured based on a biological specimen obtained from the patient, and the numerical value of the ratio of the actual presence of the virulent CD4+CTCL cells in the specific in-body section is considered as a numerical value falling in a range around ±10% of the measurement value. p140分子を発現するCD4+細胞の比率の値を、前記患者から得られた生物学的試料を基に測定し、そして、悪性CD4+CTCL細胞の、現実に前記体内区分に存在する比率の数値は、前記測定値の約±10%の範囲内に入る数値と考える。 - 特許庁